Antimicrobial Blue Light Reduces Human-Wound Pathogens’ Resistance to Tetracycline-Class Antibiotics in Biofilms
Cells · 2025
DOI: 10.3390/cells14030219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Laisa Bonafim Negri und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital (MGH), Boston, MA 02114, USA. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Light, Drug Resistance, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, United States Department of Defense, Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), Department of Physical Medicine & Rehabilitation, Uniformed Services Uni….
Abstract (Originalsprache)
Biofilms contribute to chronic infections and the development of antimicrobial resistance (AMR). We are developing an antimicrobial blue light (aBL) device to reduce bacterial bioburden in wounds and decrease reliance on systemic antibiotics. aBL induces the generation of reactive oxygen species (ROS) through photoexcitation of endogenous chromophores, causing bacterial damage and death. This study explores the combination of tetracyclines (TCs) with aBL for the treatment of biofilm infections in vitro. Tetracyclines (TCs), including second-generation minocycline (MC), doxycycline (DOCT), and third-generation agents omadacycline (OM) and tigecycline (TG), were evaluated for their ability to enhance bactericidal effects and ROS production during aBL treatment of abiotic biofilm. TCs were tested under dark conditions and with varying aBL light parameters against biofilms of methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (PA), and Escherichia coli (E. coli). Results showed that TCs alone were ineffective against these biofilm cultures. However, when combined with aBL either before or after TC treatment, significant enhancement of microbicidal activity was observed. When the aBL is added before the TCs, there was equivalent bactericidal effect, indicating that TCs primary action against biofilms were not as photosensitizers. These findings suggest that aBL can significantly enhance the antimicrobial activity of TCs, potentially offering a new effective approach to treating biofilm-associated infections and combating AMR when aBL is applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellman Center for Photomedicine, Massachusetts General Hospital (MGH), Boston, MA 02114, USA.
- Vaccine & Immunotherapy Center, Division of Infectious Diseases, Massachusetts General Hospital (MGH), Boston, MA 02114, USA.
- Department of Dermatology, Massachusetts General Hospital, Boston, MA 02114, USA.
- Department of Dermatology, Harvard Medical School, Boston, MA 02114, USA.
- School of Medicine, University of Edinburgh, Edinburgh EH16 4UX, UK.
- Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Sandeep Korupolu, Robert W Redmond, Kristin H Gilchrist, Jeffrey A Gelfand
Förderung
- NCATS NIH HHS
- United States Department of Defense
- Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), Department of Physical Medicine & Rehabilitation, Uniformed Services Uni…
- Uniformed Services University of the Health Sciences
- Harvard Catalyst
Zitieren
APA
Negri, L. B., Korupolu, S., Farinelli, W., Jolly, A. K., Redmond, R. W., Aggarwal, S., Rahme, L. G., Gilchrist, K. H., Anderson, R. R., & Gelfand, J. A. (2025). Antimicrobial Blue Light Reduces Human-Wound Pathogens’ Resistance to Tetracycline-Class Antibiotics in Biofilms. Cells. https://doi.org/10.3390/cells14030219
Vancouver
Negri LB, Korupolu S, Farinelli W, Jolly AK, Redmond RW, Aggarwal S, et al. Antimicrobial Blue Light Reduces Human-Wound Pathogens’ Resistance to Tetracycline-Class Antibiotics in Biofilms. Cells. 2025. doi:10.3390/cells14030219
BibTeX
@article{Negri2025,
author = {Negri, Laisa Bonafim and Korupolu, Sandeep and Farinelli, William and Jolly, Alexis K and Redmond, Robert W and Aggarwal, Shifu and Rahme, Laurence G and Gilchrist, Kristin H and Anderson, R Rox and Gelfand, Jeffrey A},
title = {Antimicrobial Blue Light Reduces Human-Wound Pathogens’ Resistance to Tetracycline-Class Antibiotics in Biofilms},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14030219}
}
EUVIMED